Literature DB >> 9508300

U.S. case report of cerebral phaeohyphomycosis caused by Ramichloridium obovoideum (R. mackenziei): criteria for identification, therapy, and review of other known dematiaceous neurotropic taxa.

D A Sutton1, M Slifkin, R Yakulis, M G Rinaldi.   

Abstract

We report a case of cerebral phaeohyphomycosis in a 36-year-old male caused by the neurotropic fungus Ramichloridium obovoideum (Matushima) de Hoog 1977 (Ramichloridium mackenziei Campbell et Al-Hedaithy 1993). This man resided in the Middle East, where the fungus appears to be endemic and, possibly, geographically restricted, since all previous reports of brain abscesses due to this organism have been for patients indigenous to this area. As a servant of the Saudi Arabian royal family, he appeared in the United States seeking treatment for chronic weight loss, fatigue, decreased memory, and a more recent 2-week history of right-hand weakness which worsened to involve the entire right upper extremity. On the day prior to his admission, he had a focal motor seizure with rotation of the head and eyes to the right, followed by secondary generalization. A computerized tomogram showed a ring-enhancing hypodense lesion in the left parietal subcortical region with associated edema and mass effect. Diagnosis of a fungal etiology was made following a parietal craniotomy and excisional biopsy by observation of septate, dematiaceous hyphal elements 2 to 3 microm in width on hematoxylin-and-eosin-stained sections from within areas of inflammation and necrosis. Culture of the excised material grew out a dematiaceous mould which was subsequently identified as R. obovoideum. At two months postsurgery and with a regimen of 200 mg of itraconazole twice a day, the patient was doing well and returned to Saudi Arabia. His condition subsequently deteriorated, however, and following a 7-month course of itraconzole, he expired. We use this case to alert clinicians and personnel in clinical mycology laboratories of the pathogenicity of this organism and its potential occurrence in patients with central nervous system signs and symptoms who have resided in the Middle East and to review and/or compare R. obovoideum with other neurotropic, dematiaceous taxa and similar nonneurotropic, dematiaceous species.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9508300      PMCID: PMC104613          DOI: 10.1128/JCM.36.3.708-715.1998

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  [Case of cutaneous chromoblastomycosis with fatal cerebral metastasis].

Authors:  R FUKUSHIRO; S KAGAWA; S NISHIYAMA; H TAKAHASHI
Journal:  Presse Med       Date:  1957-12-25       Impact factor: 1.228

2.  Successful treatment of systemic Exophiala dermatitidis infection in a patient with chronic granulomatous disease.

Authors:  R T Kenney; K J Kwon-Chung; A T Waytes; D A Melnick; H I Pass; M J Merino; J I Gallin
Journal:  Clin Infect Dis       Date:  1992-01       Impact factor: 9.079

3.  Some medically important fungi and their common synonyms and obsolete names.

Authors:  M R McGinnis; M G Rinaldi
Journal:  Clin Infect Dis       Date:  1997-07       Impact factor: 9.079

Review 4.  Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections. Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards.

Authors:  J H Rex; M A Pfaller; J N Galgiani; M S Bartlett; A Espinel-Ingroff; M A Ghannoum; M Lancaster; F C Odds; M G Rinaldi; T J Walsh; A L Barry
Journal:  Clin Infect Dis       Date:  1997-02       Impact factor: 9.079

5.  Phaehyphomycosis caused by Veronea bothryosa.

Authors:  A Ayadi; M R Huerre; C de Bievre
Journal:  Lancet       Date:  1995 Dec 23-30       Impact factor: 79.321

Review 6.  Chromomycosis in Japan.

Authors:  R Fukushiro
Journal:  Int J Dermatol       Date:  1983-05       Impact factor: 2.736

7.  Intracranial mycotic infections in neurosurgical practice.

Authors:  A B Jamjoom; S A al-Hedaithy; Z A Jamjoom; M al-Hedaithy; S F el-Watidy; N Rahman; M al-Moallem
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 8.  Systemic phaeohyphomycosis caused by Exophiala dermatitidis.

Authors:  M Hiruma; A Kawada; H Ohata; Y Ohnishi; H Takahashi; M Yamazaki; A Ishibashi; K Hatsuse; M Kakihara; M Yoshida
Journal:  Mycoses       Date:  1993 Jan-Feb       Impact factor: 4.377

9.  Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi.

Authors:  A Espinel-Ingroff; K Dawson; M Pfaller; E Anaissie; B Breslin; D Dixon; A Fothergill; V Paetznick; J Peter; M Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

10.  Fatal cerebral mycoses caused by the ascomycete Chaetomium strumarium.

Authors:  S P Abbott; L Sigler; R McAleer; D A McGough; M G Rinaldi; G Mizell
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

View more
  14 in total

1.  Femur osteomyelitis due to a mixed fungal infection in a previously healthy man.

Authors:  M Cimerman; N Gunde-Cimerman; P Zalar; T Perkovic
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ("Ramichloridium mackenziei").

Authors:  H M Al-Abdely; L Najvar; R Bocanegra; A Fothergill; D Loebenberg; M G Rinaldi; J R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

3.  Cerebral phaeohyphomycosis caused by Rhinocladiella mackenziei in a woman native to Afghanistan.

Authors:  Alejandro Cristini; Dea Garcia-Hermoso; Marie Celard; Gilles Albrand; Olivier Lortholary
Journal:  J Clin Microbiol       Date:  2010-06-30       Impact factor: 5.948

4.  Acrophialophora fusispora brain abscess in a child with acute lymphoblastic leukemia: review of cases and taxonomy.

Authors:  I Z Al-Mohsen; D A Sutton; L Sigler; E Almodovar; N Mahgoub; H Frayha; S Al-Hajjar; M G Rinaldi; T J Walsh
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

5.  Disseminated zygomycosis due to Rhizopus schipperae after heatstroke.

Authors:  G M Anstead; D A Sutton; E H Thompson; I Weitzman; R A Otto; S K Ahuja
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

Review 6.  Melanized fungi in human disease.

Authors:  Sanjay G Revankar; Deanna A Sutton
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

7.  Fonsecaea pugnacius, a Novel Agent of Disseminated Chromoblastomycosis.

Authors:  Conceição M P S de Azevedo; Renata R Gomes; Vania A Vicente; Daniel W C L Santos; Sirlei G Marques; Mariana M F do Nascimento; Caroline E W Andrade; Raimunda R Silva; Flávio Queiroz-Telles; G Sybren de Hoog
Journal:  J Clin Microbiol       Date:  2015-06-17       Impact factor: 5.948

8.  First autochthonous case of Rhinocladiella mackenziei cerebral abscess outside the Middle East.

Authors:  Hamid Badali; Jagdish Chander; Shaifali Bansal; Atul Aher; Surendra S Borkar; Jacques F Meis; G Sybren De Hoog
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

Review 9.  Invasive mycotic infections caused by Chaetomium perlucidum, a new agent of cerebral phaeohyphomycosis.

Authors:  M A Barron; D A Sutton; R Veve; J Guarro; M Rinaldi; E Thompson; P J Cagnoni; K Moultney; N E Madinger
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

10.  Phylogenetic and morphotaxonomic revision of Ramichloridium and allied genera.

Authors:  M Arzanlou; J Z Groenewald; W Gams; U Braun; H-D Shin; P W Crous
Journal:  Stud Mycol       Date:  2007       Impact factor: 16.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.